This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: National Institute of Health and Medical Research, Universite Rene Descartes. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2012
Title: J Guilherme Tralhao: Innovator in Liver Regeneration
Introduction
J Guilherme Tralhao is a notable inventor based in Coimbra, Portugal. He has made significant contributions to the field of liver regeneration through his innovative research and patent. His work focuses on the therapeutic potential of HIP/PAP polypeptide composition in preventing liver failure and promoting liver regeneration.
Latest Patents
Tralhao holds a patent for a "Method for using HIP/PAP polypeptide composition for liver regeneration and prevention of liver failure." This invention is grounded in the experimental findings that HIP/PAP exhibits mitogenic and anti-apoptotic effects on hepatocytes in primary culture. Furthermore, HIP/PAP has been shown to be effective in vivo during liver failure and regeneration without adverse effects in mammals. The patent details a pharmaceutical composition designed to stimulate liver regeneration, particularly after chronic or acute liver failure, comprising a polypeptide with a specific amino acid sequence.
Career Highlights
Throughout his career, Tralhao has worked with prestigious institutions, including the Institut National de la Santé et de la Recherche Médicale and Université René Descartes. His research has contributed to advancements in medical science, particularly in the area of liver health.
Collaborations
Tralhao has collaborated with Laurence Christa, enhancing the scope and impact of his research endeavors.
Conclusion
J Guilherme Tralhao's innovative work in liver regeneration exemplifies the potential of scientific research to address critical health challenges. His contributions through patents and collaborations continue to influence the field positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile